Fred Alger Management’s Dianthus Therapeutics DNTH Stock Holding History

Fred Alger Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127M	Buy	1,302,493 +140,570	+12%	+$12.3M	0.42%	34
2026 Q1	$97.5M	Buy	1,161,923 +1,128,463	+3,373%	+$65.3M	0.43%	36
2025 Q4	$1.38M	Sell	33,460 -11,844	-26%	-$459K	0.01%	338
2025 Q3	$1.78M	Buy	+45,304	New	+$1.16M	0.01%	328
2024 Q4	–	Sell	-9,633	Closed	-$264K	–	425
2024 Q3	$264K	Buy	9,633 +3,316	+52%	+$92.4K	﹤0.01%	396
2024 Q2	$163K	Sell	6,317 -30,050	-83%	-$722K	﹤0.01%	393
2024 Q1	$1.09M	Sell	36,367 -4,474	-11%	-$97.2K	0.01%	369
2023 Q4	$425K	Buy	+40,841	New	+$451K	﹤0.01%	402
2021 Q2	–	Sell	-4,969	Closed	-$941K	–	518
2021 Q1	$941K	Buy	+4,969	New	+$836K	﹤0.01%	392

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Fred Alger Management's DNTH Position: Q2 2026 in Review

Fred Alger Management increased its Dianthus Therapeutics (DNTH) stake by 12% in Q2 2026, buying an estimated $12.3M and bringing the position to 1,302,493 shares worth $127M. The position accounts for 0.42% of the portfolio, ranked #34.

Fred Alger Management first reported a position in DNTH in Q1 2021 and has held it in 9 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Fred Alger Management held 1,302,493 shares of Dianthus Therapeutics worth $127M as of Q2 2026.
Fred Alger Management bought 140,570 Dianthus Therapeutics shares in Q2 2026, an estimated $12.3M.
Dianthus Therapeutics made up 0.42% of Fred Alger Management's portfolio in Q2 2026, its #34 holding.
Fred Alger Management first reported a position in Dianthus Therapeutics in Q1 2021 and has held it in 9 quarters since.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.